| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SERPINB10 |
SERPINB10, PI10: Serpin B10 |
0.265 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
SLC14A1 |
SLC14A1, HUT11, JK, RACH1, UT1, UTE: Urea transporter, erythrocyte |
0.265 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
MFGE8 |
MFGE8: Lactadherin precursor |
0.265 |
Evidence |
|
| SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
CA14 |
CA14, UNQ690/PRO1335: Carbonic anhydrase 14 precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C20orf71 |
C20orf71: C20orf71 protein |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C20orf114 |
LPLUNC1, C20orf114, UNQ706/PRO1357: Long palate, lung and nasal epithelium carci |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
BPIL2 |
BPIL2: Bactericidal/permeability-increasing protein-like 2 precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
BPIL3 |
BPIL3: Bactericidal/permeability-increasing protein-like 3 precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
BPIL1 |
BPIL1, C20orf184, UNQ2489/PRO5776, LPLUNC2: Bactericidal/permeability-increasing |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C20orf186 |
LPLUNC4, C20orf186: Long palate, lung and nasal epithelium carcinoma-associated |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C20orf185 |
C20orf185, LPLUNC3: Long palate, lung and nasal epithelium carcinoma-associated |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
C20orf71 |
C20orf71: C20orf71 protein |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
C20orf114 |
LPLUNC1, C20orf114, UNQ706/PRO1357: Long palate, lung and nasal epithelium carci |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
BPIL2 |
BPIL2: Bactericidal/permeability-increasing protein-like 2 precursor |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
BPIL3 |
BPIL3: Bactericidal/permeability-increasing protein-like 3 precursor |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
BPIL1 |
BPIL1, C20orf184, UNQ2489/PRO5776, LPLUNC2: Bactericidal/permeability-increasing |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
C20orf186 |
LPLUNC4, C20orf186: Long palate, lung and nasal epithelium carcinoma-associated |
0.265 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
C20orf185 |
C20orf185, LPLUNC3: Long palate, lung and nasal epithelium carcinoma-associated |
0.265 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
C20orf71 |
C20orf71: C20orf71 protein |
0.265 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
C20orf114 |
LPLUNC1, C20orf114, UNQ706/PRO1357: Long palate, lung and nasal epithelium carci |
0.265 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
BPIL2 |
BPIL2: Bactericidal/permeability-increasing protein-like 2 precursor |
0.265 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
BPIL3 |
BPIL3: Bactericidal/permeability-increasing protein-like 3 precursor |
0.265 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
BPIL1 |
BPIL1, C20orf184, UNQ2489/PRO5776, LPLUNC2: Bactericidal/permeability-increasing |
0.265 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
C20orf186 |
LPLUNC4, C20orf186: Long palate, lung and nasal epithelium carcinoma-associated |
0.265 |
Evidence |
|